Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Neurology | Psychiatry/Psychology
Search Medical Condition
Memory Loss Clinical Trials
A listing of Memory Loss medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (65) clinical trials
A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease.
This study seeks to evaluate the efficacy and safety of ABBV-8E12 in subjects with Early Alzheimer's Disease.
A Placebo-Controlled, Double-Blind, Parallel-Group, 24 Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
The name of this trial is MissionAD1. This 24-month treatment, multicenter, double-blind, placebo-controlled, parallel group, Phase 3 study in participants with Early Alzheimer's Disease (EAD) including mild cognitive impairment (MCI) due to AD/Prodromal AD and the early stages of mild AD will be conducted to evaluate the efficacy and safety ...
Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease
This Phase III study is designed as a randomized, double-blinded, placebo-controlled study for subjects with evidence of early AD. The study will evaluate safety and tolerability, efficacy as measured by CDR-SB, and will determine if the combination therapy ALZT-OP1 will slow down, arrests, or reverse cognitive and functional decline in ...
Mild Dementia/Alzheimer's Disease
Northern California Research is enrolling participants for a Mild Dementia/Alzheimer's Disease study. The purpose of this study is to see if daily doses of a study medication will improve the symptoms of mild dementia due to Alzheimer's disease. This study medication has been designed to change the cortisol levels in ...
Clinical Research for Patient with Mild Cognitive Impairment due to Alzheimer's Disease or Mild to Moderate Alzheimer’s Disease disease
If you qualify, the study may involve 3 screening visits, 1 separate in-clinic stay of 5 days/4 nights and 10 outpatient visits. All study exams and procedures are provided at no cost to you. You do not need medical insurance to participate.
A Phase 3, double blind, randomized study of RVT-101 versus placebo when added to existing stable donepezil treatment in subjects with mild to moderate Alzheimer’s disease; RVT-101-3001
This Study is for patients that have mild to moderate Alzheimer's disease that are on a stable therapy with donepezil.
Clinical study evaluating treatment for Alzheimer's disease
The purpose of this study is to evaluate Donepezil and Memantine for the treatment of Alzheimer's disease.
An Efficacy and Safety Study of LY3314814 in Early Alzheimer's Disease (AMARANTH)
SPRI is currently participating in a multi-center, 24-month clinical evaluation of an investigational drug for people suffering from mild cognitive impairment (MCI) or mild Alzheimer’s disease (AD).
A clinical research study to evaluate the added benefit of an investigational drug in people with moderate Alzheimer’s disease who are currently taking stable doses of Donepezil and either Memantine or Namenda XR.
SPRI Clinical Trials of Brooklyn, under the sponsorship of Suven Life Sciences, is currently participating in the clinical evaluation of the safety and effectiveness of an investigational drug in persons with moderate dementia due to Alzheimer’s disease.
Have you had a slow progression of memory decline in the last year or so?
A Research Study is being conducted to evaluate an oral investigational medication that may help slow down the progression of what could be very early Alzheimer’s disease. Prodromal Alzheimer’s disease is the very early stage of the disease when minor symptoms first appear. A diagnosis can only be confirmed through ...
